NSPR Insider Trading (InspireMD)
Insider Ownership Percentage: 3.80%
Insider Buying (Last 12 Months): $434,581.69
Insider Selling (Last 12 Months): $0.00
InspireMD Share Price & Price History
Current Price: $1.92
Price Change: ▼ Price Decrease of -0.01 (-0.52%)
As of 08/10/2022 01:00 AM ET
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
InspireMD Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|12/28/2021||Gary S Roubin||Director||Buy||16,393||$3.08||$50,490.44|| |
|12/1/2021||Paul Stuka||Director||Buy||12,037||$3.51||$42,249.87|| |
|11/29/2021||Paul Stuka||Director||Buy||3,177||$3.55||$11,278.35|| |
|11/26/2021||Paul Stuka||Director||Buy||1,200||$3.55||$4,260.00|| |
|11/24/2021||Paul Stuka||Director||Buy||18,328||$3.55||$65,064.40|| |
|11/22/2021||Paul Stuka||Director||Buy||19,188||$3.54||$67,925.52|| |
|11/17/2021||Gary S Roubin||Director||Buy||25,930||$3.86||$100,089.80|| |
|8/25/2021||Gary S. Roubin||Director||Buy||22,249||$4.19||$93,223.31|| |
|2/8/2021||Marvin Slosman||CEO||Buy||40,320||$0.62||$24,998.40|| |
|2/8/2021||Thomas J. Kester||Director||Buy||120,960||$0.62||$74,995.20|| |
|10/16/2020||Gary S. Roubin||Director||Buy||222,223||$0.45||$100,000.35|| |
|6/3/2020||Thomas J. Kester||Director||Buy||50,000||$0.50||$25,000.00|| |
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
InspireMD Institutional Trading History
Data available starting January 2016
|Reporting Date||Hedge Fund||Shares Held||Market Value||% of Portfolio||Quarterly Change in Shares||Ownership in Company||Details|
|2/10/2022||HighTower Advisors LLC||26,567||$81K||0.0%||+60.4%||0.329%|
|2/1/2022||Avestar Capital LLC||10,000||$30K||0.0%||N/A||0.124%|
|11/15/2021||HighTower Advisors LLC||16,567||$68K||0.0%||N/A||0.205%|
|8/17/2021||Bridgeway Capital Management LLC||36,667||$0.18M||0.0%||+22.2%||0.463%|
|8/13/2021||Renaissance Technologies LLC||81,263||$0.41M||0.0%||-97.4%||1.027%|
|8/11/2021||Susquehanna Fundamental Investments LLC||17,901||$90K||0.0%||N/A||0.226%|
|5/18/2021||Jane Street Group LLC||112,002||$75K||0.0%||N/A||1.417%|
|5/13/2021||Renaissance Technologies LLC||3,127,521||$2.10M||0.0%||+151.6%||39.559%|
|5/7/2021||Tobias Financial Advisors Inc.||40,000||$27K||0.0%||N/A||0.509%|
|4/27/2021||United Asset Strategies Inc.||70,000||$47K||0.0%||N/A||0.059%|
|2/10/2021||Renaissance Technologies LLC||1,243,100||$0.42M||0.0%||+753.5%||1.730%|
|10/20/2020||Wedbush Securities Inc.||230,508||$73K||0.0%||+91.3%||0.691%|
|7/16/2020||Wedbush Securities Inc.||120,508||$56K||0.0%||+211.6%||2.777%|
|1/16/2020||Wedbush Securities Inc.||60,633||$65K||0.0%||+102.1%||1.669%|
|11/27/2019||Sabby Management LLC||313,572||$0.41M||0.2%||+2,018.7%||8.634%|
|10/17/2019||Wedbush Securities Inc.||30,000||$39K||0.0%||N/A||2.144%|
|8/12/2019||Bank of New York Mellon Corp||23,946||$82K||0.0%||N/A||1.763%|
|1/16/2019||Virtu Financial LLC||291,021||$46K||0.0%||+1,305.7%||0.774%|
|2/13/2017||Renaissance Technologies LLC||109,742||$0.27M||0.0%||-94.3%||7.664%|
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of InspireMD?